ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up

scientific article published in June 2008

ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/TP.0B013E3181726849
P698PubMed publication ID18580466

P2093author name stringUlla Berg
Gunilla Kumlien
Gunnar Tydén
Helena Genberg
Lars Wennberg
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectrituximabQ412323
P304page(s)1745-1754
P577publication date2008-06-01
P1433published inTransplantationQ15730500
P1476titleABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up
P478volume85

Reverse relations

cites work (P2860)
Q38306136A systematic review of the use of rituximab as induction therapy in renal transplantation
Q87273092AB0 incompatible kidney transplantation using unspecific immunoadsorption
Q35607565ABO Incompatible Kidney Transplantation-Current Status and Uncertainties
Q51762531ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial.
Q37803412ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?
Q28236829ABO incompatible renal transplants: Good or bad?
Q90252745ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis
Q36696495ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier.
Q35524699ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier
Q38325273Adsorption of chain type-specific ABO antibodies on Sepharose-linked A and B tetrasaccharides
Q36066503Alternative Living Kidney Donation Programs Boost Genetically Unrelated Donation
Q38267202An update on ABO-incompatible kidney transplantation
Q37800331Antibody immunosuppressive therapy in solid organ transplant
Q38286995Antibody-incompatible kidney transplantation in 2015 and beyond
Q37990988Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale
Q42038591B-cell tolerance in transplantation: is repertoire remodeling the answer?
Q34159016B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.
Q37994745Beyond dialysis: current and emerging blood purification techniques.
Q26829578Biologics in organ transplantation
Q94661248Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy
Q90047669Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis
Q38445752Comparative analysis of ABO-incompatible living donor kidney transplantation with ABO-compatible grafts: a single-center experience in Korea
Q37834028Current immunosuppressive treatment after kidney transplantation
Q36171175Current progress in ABO-incompatible kidney transplantation
Q98727034Current protocols and outcomes of ABO-incompatible kidney transplantation
Q37547425Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children
Q38001495Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?
Q38460398Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation
Q40815282Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations
Q38680131Discontinuation of steroids in ABO-incompatible renal transplantation.
Q35543289Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.
Q51955356Effects of B cell depletion on T cell allogeneic immune responses: a strategy to reduce allogeneic sensitization.
Q58999579Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients
Q36400872Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center
Q37766166Immunogenicity and allogenicity: a challenge of stem cell therapy
Q37830813Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy
Q36126901Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients
Q28741418Incompatible live-donor kidney transplantation in the United States: results of a national survey
Q50987486Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.
Q35664634Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin
Q35953320Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation
Q38006827Innovative strategies in living donor kidney transplantation
Q37776364Isoagglutinin adsorption in ABO-incompatible transplantation
Q45972317Isoagglutinin titre adsorption: breaking the barrier in major AB0-incompatible organ transplantation.
Q50177273Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation.
Q100517385Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report
Q38570443Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis
Q34786113Mimotope selection of blood group A antigen from a phage display 15-mer peptide library
Q27010224Modern approaches to incompatible kidney transplantation
Q26826880Monoclonal antibody therapy and renal transplantation: focus on adverse effects
Q37901973Neurological complications of transplantation
Q40271255One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience
Q35822937Outcomes of ABO-incompatible kidney transplantation in the United States
Q91554083Percentage of CD19+ Cells in Peripheral Blood Lymphocytes After Rituximab-Based Desensitization as a Predictor of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation
Q37369319Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.
Q41527816Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Q37989298Rituximab in immunologic glomerular diseases
Q48511018Safety and Efficacy of Induction Therapy With Thymoglobulin in AB0-Incompatible Kidney Transplantation
Q38468859Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts
Q89029586Similar Microvascular Inflammation and Tubulointerstitial Injury in ABO-Incompatible and Matched ABO-Compatible Kidney Allografts
Q39903845Specific issues in living donor kidney transplantation: ABO - incompatibility
Q35022239Strategies to increase the donor pool and access to kidney transplantation: an international perspective
Q40503602Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases
Q37615262The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience
Q38118112Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.
Q84453096Transplantation: ABO-incompatible renal transplants: time for increased use?
Q33396236Use of monoclonal antibodies in renal transplantation
Q43982164Vienna experience of ABO-incompatible living-donor kidney transplantation
Q84867357[Extending the donor pool in renal transplantation]

Search more.